Antipsychotic Drugs in Bipolar Disorder

This article reviews the use of antipsychotic drugs in the treatment of acute mania & as maintenance treatment. The evidence for the use of atypical antipsychotic drugs, including their effects on suicidal behaviours, is discussed. Clozapine, risperidone, olanzapine, & other atypic antipsychotics are reviewed. (59 refs.)

Strategies to Prevent Suicide

These letters to the editor comment on a previous article by Mann et al (2005) on suicide prevention strategies. Tondo & Baldessarini note the lack of discussion of disorders other than major depression & treatments other than antidepressants. Knox & Caine provide more information on the Air Force Suicide Prevention Program, disputing Mann et al’s […]

Detection and Management of Comorbidity in Patients With Schizophrenia

~

Impact of Clozapine on Completed Suicide

For commentary on this article and reactions to these findings, please see SIEC #2005-0085

Symptom Reduction and Suicide Risk Among Patients Treated With Placebo in Antipsychotic Trials: an Analysis of the Food and Drug Administration Database

~

Clozapine and Suicide

For the original article by Sernyak et al., please see SIEC #2005-0078

Clozapine and Postmortem Redistribution

The authors present a case study in which a patient being treated with clozapine was found dead with toxic levels of the drug in her blood. While the coroner expressed concern over the possibility of suicide, the authors argue that the elevated drug concentrations might instead have been caused by a postmortem redistribution of clozapine […]

The Pharmacovigilance of Olanzapine: Results of a Post-Marketing Surveillance Study on 8858 Patients in England

~

Comparative Study of Mortality Rates and Cardiac Dysrhythmias in Post-Marketing Surveillance Studies of Sertindole and two Other Atypical Antipsychotic Drugs…

~

The Barnes Akathisia Rating Scale – Revisited

~

Decreasing Suicide in Schizophrenia

For Part 1 of this series, please see SIEC #2005-0439

Decreasing Suicide in Schizophrenia

For Part 2 of this series, please see SIEC #2005-0438

Suicide Victims With Schizophrenia in Different Treatment Phases and Adequacy of Antipsychotic Treatment

Published in “The Suicidal Process: Challenges for Treatment and Prevention”

Pharmacotherapy of Suicidal Behavior in Bipolar Disorder

~

International Suicide Prevention Trial (Intersept): Reduced Suicidality in Schizophrenia with Clozapine Treatment

Clozapine may be More Effective than Olanzapine for Reducing Suicidal Behaviour in People with Schizophrenia at High Risk

Please see SIEC #2003-1344 for the citation to the Meltzer et al article.

A Review of Olanzapine-associated Toxicity and Fatality in Overdose

~

Re: Schizophrenia, Suicide, and Blood Count During Treatment With Clozapine

A Randomized Double-Blind Study of Risperidone and Olanzapine in the Treatment of Schizophrenia or Schizoaffective Disorder

The safety & efficacy of risperidone & olanzapine were compared in a double-blind trial that used doses widely accepted in clinical trials. During the study, serious adverse events were experienced by 8.0% of the risperidone participants & 11.6% of the olanzapine participants. The second most frequently recorded serious adverse event was suicide attempt, which was […]

Reducing the Risk for Suicide in Schizophrenia and Affective Disorders: Suicide in Schizophrenia

For a related article on treatment & suicide risks in affective disorders, please see SIEC #2004-0558

Modelling the Impact of Clozapine on Suicide in Patients With Treatment-Resistant Schizophrenia in the UK

In order to model the impact of increased clozapine prescribing on lives saved & resource utilization, a model was built to compare current levels of clozapine prescribing with a scenario in which all suitable patients with treatment-resistant schizophrenia received clozapine. It was estimated that an average of 53 lives could be saved in the UK […]

Contributions of 5-HT2C Receptors to Multiple Actions of Central Serotonin Systems

The authors discuss the contributions of a prominent central serotonin subtype, the 5-HT2C receptor, to the actions of serotonin. Evidence for a role of these receptors in affect regulation, gathered from observations of the brains of suicide victims with a history of depression, is explored. (90 refs)

Do Antipsychotic Medications Decrease the Risk of Suicide in Patients With Schizophrenia?

This review brings together evidence from controlled studies regarding the benefits provided by antipsychotic medications against suicide & suicide attemtps in schizophrenia. (43 refs)